Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CLL Progression”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Testing effectiveness (Phase 2)Study completedNCT03207555
What this trial is testing

Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Malignant Neoplasms Stated as Primary Lymphoid HaematopoieticChronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia
M.D. Anderson Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT00290810
What this trial is testing

Bevacizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia
National Cancer Institute (NCI) 12
Not applicableUnknownNCT04811950
What this trial is testing

Prognostic Role of Platelet _lymphocyte and Neutrophil _monocyte in CLL

Who this might be right for
CLL Progression
Assiut University 100
Testing effectiveness (Phase 2)UnknownNCT00892827
What this trial is testing

Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Advanced Refractory Chronic Lymphocytic Leukemia
Wolfson Medical Center 10
Testing effectiveness (Phase 2)Ended earlyNCT00899353
What this trial is testing

Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple MyelomaChronic Lymphocytic Leukemia
Marshall University 16
Testing effectiveness (Phase 2)Looking for participantsNCT03516617
What this trial is testing

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Mayo Clinic 120
Testing effectiveness (Phase 2)Study completedNCT01008462
What this trial is testing

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Prolymphocytic LeukemiaHypodiploidyLoss of Chromosome 17p+18 more
Fred Hutchinson Cancer Center 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07342478
What this trial is testing

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

Who this might be right for
CLL / SLLCLL (Chronic Lymphocytic Leukemia)CLL, Refractory+5 more
Newave Pharmaceutical Inc 306
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Early research (Phase 1)Study completedNCT01471067
What this trial is testing

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Who this might be right for
Blood And Marrow TransplantationLeukemiaLymphoma+2 more
M.D. Anderson Cancer Center 33
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Testing effectiveness (Phase 2)WithdrawnNCT04029038
What this trial is testing

Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma

Who this might be right for
CD19 PositiveCD22 PositiveMinimal Residual Disease+7 more
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT04075292
What this trial is testing

Study of Acalabrutinib Versus Chlorambucil Plus Rituximab in Adult Subjects With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Untreated Chronic Lymphocytic Leukemia
AstraZeneca 155
Testing effectiveness (Phase 2)Looking for participantsNCT03852407
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Who this might be right for
Acute Myeloid Leukemia in RemissionMyelodysplastic SyndromesChronic Myeloid Leukemia in Remission+7 more
University of Liege 114
Large-scale testing (Phase 3)Study completedNCT02863718
What this trial is testing

Ibrutinib in Previously Untreated Binet Stage a Chronic Lymphocytic Leukemia with Risk of Disease Progression

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 515
Large-scale testing (Phase 3)Study completedNCT00275054
What this trial is testing

Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 825
Testing effectiveness (Phase 2)UnknownNCT02912754
What this trial is testing

Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Sunnybrook Health Sciences Centre 36
Early research (Phase 1)Active Not RecruitingNCT03422393
What this trial is testing

Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Michael Choi 24
Large-scale testing (Phase 3)Study completedNCT00991211
What this trial is testing

Bendamustine Plus Rituximab Versus CHOP Plus Rituximab

Who this might be right for
Non-Hodgkin LymphomasFollicular LymphomasImmunocytomas+2 more
University of Giessen 549
Not applicableNot Yet RecruitingNCT06084923
What this trial is testing

Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression

Who this might be right for
Chronic Lymphocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 73
Load More Results